Glucose Health, Inc.
GLUC · OTC
9/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $2 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $2 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -20.7% | 20.3% | -12.2% | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -0.2% | 20.5% | 26.1% | -34.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -110.8% | -90.8% | -102.2% | -138.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -130.4% | -99.4% | -103.5% | -144.3% |
| EPS Diluted | -0.006 | -0.006 | -0.005 | -0.007 |
| % Growth | 6.8% | -22.9% | 31.4% | – |
| Operating Cash Flow | – | -$0 | -$0 | -$0 |
| Capital Expenditures | – | -$0 | $0 | -$0 |
| Free Cash Flow | – | -$0 | -$0 | -$0 |